Possible coronavirus treatment drug announced by US biotech company
Medicine in use since the first wave
La chloroquine sera utilisée en Polynésie
Impaired-interferon response: A life-threat to some COVID patients
How Chinese hospitals treated COVID-19
Lopinavir/ritonavir (LPV/r), sold under the brand name Kaletra among others, is a fixed dose combination medication for the treatment and prevention of HIV/AIDS. It combines lopinavir with a low dose of ritonavir. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth as a tablet, capsule, or solution.